The Procalcitonin and Survival Study

NACompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Localized InfectionSepsisMultiple Organ Failure
Interventions
PROCEDURE

Earlier therapeutic changes regarding infection

For every day Procalcitonin levels increase in the intervention group, antibiotics, surgery, diagnostic imaging and microbiologic testing is intensified

Trial Locations (9)

DK-8000

Intensive Care Unit, Århus Sygehus, Nørrebrogade, Aarhus

DK-8200

Skejby Sygehus, Skejby, Århus

DK-2400

Intensive Care Unit, Bispebjerg Hospital, Copenhagen NV

DK-2820

Intensive Care Unit, KAS Gentofte, Gentofte Municipality

DK-2600

Intensive Care Unit, KAS Glostrup, Copenhagen University Hospital, Glostrup Municipality

DK-2730

Intensive Care Unit, Herlev Hospital, Herlev

DK-2650

Intensive Care Unit 542, Hvidovre Hospital, Copenhagen University Hospital, Hvidovre

DK-3400

Intensive Care Unit, Hilleroed Sygehus, Hilleroed

DK-4000

Roskilde Sygehus, Roskilde

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Copenhagen HIV Programme

OTHER_GOV

collaborator

Danish Research Agency

OTHER

collaborator

Hvidovre University Hospital

OTHER

lead

Danish Procalcitonin Study Group

OTHER

NCT00271752 - The Procalcitonin and Survival Study | Biotech Hunter | Biotech Hunter